This study investigates advanced pancreatic cancer. The purpose of this study is to explore how a combination of treatments might work for this condition.
The study evaluates the safety and effectiveness of these treatments. Researchers will look into how well they work and if they are safe for patients.
- Who can participate: Adults aged 18 to 75 with advanced pancreatic cancer can join. Participants must not have had prior systemic therapy for their condition, need to have measurable lesions, and must have an ECOG physical status score of 0 or 1.
- Study details: Participants will receive investigational treatments including injections. The study focuses on the administration and effects of these investigational treatments.